BSEBoard Meeting6d ago · 29 Jul 2026, 02:36 pm

Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. The Unaudited Financial ....

Gennex Laboratories Ltd · 531739

✦ AI SummaryResults

Gennex Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 to consider and approve the Unaudited Financial Statements for the Quarter ended June 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gennex Laboratories Ltd - 531739 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.

Attachments (1)

📄

cfb74261-d925-4aeb-96a2-87800b097750.pdf

pdf

Download →
View document text
Ref: GLL/SE/2026-27/July - ———y—eu can trust Date: 29/07/2026 To To The General Manager, The Listing Manager, Corporate Relations Department, The Ahmedabad Stock Exchange Limited BSE Limited A-2, Kamdhenu Complex, Phiroze Jeejeebhoy Towers, Opp. Sahajanand College, Dalal Street, Mumbai - 400001. 120 Feet Ring Road, Panjara Pol, Ambawadi, Maharashtra State, India. Ahmedabad - 380015. Script Code: 531739 Gujarat State, India. Script Code: The Calcutta Stock Exchange Limited, #7, Lyons Range, Murgighata, Dalhousie, Kolkata - 700001, West Bengal State, India. Script Code: 26178 Dear Sir/Madam, Sub: Intimation of Board Meeting to be held on Friday, August 14, 2026 of Gennex Laboratories Limited Ref: Regulation 29(1)(a), 33 and 47 of SEBI (LODR) Regulations, 2015 With reference to the above captioned subject matter, we hereby inform you that the Meeting of Board of Directors of the Company will be held on Friday, August 14, 2026 at 04:00 PM at the Corporate Office of the Company, inter-alia, to consider the following matters, among other items of agenda: 1. Consider and adopt the Unaudited Financial Statements (Standalone and Consolidated) for the Quarter ended June 30, 2026; 2. Consider the Limited Review Reports of the Statutory Auditor on Standalone and Consolidated Financial Statements for the Quarter ended June 30, 2026; 3. Other Business items. Further, in continuation to earlier disclosure dated June 23, 2026, regarding the closure of trading window w.e.f. July 01, 2026 in pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, Trading Window for dealing in the securities of the Company shall open after 48 hours of declaration of Unaudited Financial Results for the quarter ended June 30, 2026 for all designated persons, their immediate relatives and all connected persons covered under the aforesaid code. This intimation is also being uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge receipt of the same. Thanking you, Yours faithfully For Gen boratories Limited Dinesh Kumar Kejriwal “| a \R ‘ Company Secretary & Compliance Officer». Membership #A19293 NG Gennex Laboratories Limited Akash Ganga, 4th Floor, Plot No.144, Srinagar Colony, Hyderabad-500073, Telangana State, India | Tel : +91-40-67334400 (30 Lines), 23746451 Factory : Sy.No.133, Bollaram Village, Jinnaram Mandal, Sangareddy Dist - 502 325, Telangana State, India. Tel : +91-08458 295516, info@gennexlab.com, www.gennexlab.com ff CIN : L24230TG1990PLC011168